Operating Margin in % of Travere Therapeutics, Inc. from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Travere Therapeutics, Inc. quarterly/annual Operating Margin history and change rate from 2016 to Q3 2025.
  • Travere Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2025 was -20.9 %, a 88.1% increase year-over-year.
  • Travere Therapeutics, Inc. annual Operating Margin for 2024 was -139 %, a 48% increase from 2023.
  • Travere Therapeutics, Inc. annual Operating Margin for 2023 was -267 %, a 8.53% increase from 2022.
  • Travere Therapeutics, Inc. annual Operating Margin for 2022 was -292 %, a 93.2% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Travere Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -20.9 +155 +88.1% Jul 1, 2025 Sep 30, 2025
Q2 2025 -51.6 +170 +76.7% Apr 1, 2025 Jun 30, 2025
Q1 2025 -83.1 +193 +69.9% Jan 1, 2025 Mar 31, 2025
Q4 2024 -139 +128 +48% Oct 1, 2024 Dec 31, 2024
Q3 2024 -176 +118 +40.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -222 +85.9 +27.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -276 +19.1 +6.46% Jan 1, 2024 Mar 31, 2024
Q4 2023 -267 +24.9 +8.53% Oct 1, 2023 Dec 31, 2023
Q3 2023 -294 +468 +61.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -308 +18.7 +5.73% Apr 1, 2023 Jun 30, 2023
Q1 2023 -295 -87.6 -42.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -292 -141 -93.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -762 -657 -623% Jul 1, 2022 Sep 30, 2022
Q2 2022 -326 -218 -202% Apr 1, 2022 Jun 30, 2022
Q1 2022 -208 -102 -96.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -151 -62.4 -70.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -105 -61.2 -138% Jul 1, 2021 Sep 30, 2021
Q2 2021 -108 -54.4 -101% Apr 1, 2021 Jun 30, 2021
Q1 2021 -105 -43.2 -69.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -88.8 -10.5 -13.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -44.2 +22 +33.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.8 +14.5 +21.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -62.2 -1.54 -2.54% Jan 1, 2020 Mar 31, 2020
Q4 2019 -78.3 -29.6 -60.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -66.2 -10.8 -19.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -68.3 -28.1 -70% Apr 1, 2019 Jun 30, 2019
Q1 2019 -60.7 -24.8 -69.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -48.7 -14 -40.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -55.5 Jul 1, 2018 Sep 30, 2018
Q2 2018 -40.2 Apr 1, 2018 Jun 30, 2018
Q1 2018 -35.9 Jan 1, 2018 Mar 31, 2018
Q4 2017 -34.7 Oct 1, 2017 Dec 31, 2017

Travere Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -139 +128 +48% Jan 1, 2024 Dec 31, 2024
2023 -267 +24.9 +8.53% Jan 1, 2023 Dec 31, 2023
2022 -292 -141 -93.2% Jan 1, 2022 Dec 31, 2022
2021 -151 -62.4 -70.3% Jan 1, 2021 Dec 31, 2021
2020 -88.8 -10.5 -13.4% Jan 1, 2020 Dec 31, 2020
2019 -78.3 -29.6 -60.8% Jan 1, 2019 Dec 31, 2019
2018 -48.7 -14 -40.4% Jan 1, 2018 Dec 31, 2018
2017 -34.7 +8.86 +20.3% Jan 1, 2017 Dec 31, 2017
2016 -43.6 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.